Queen's gambit: response-adapted win in CAYA with cHL
- PMID: 37103949
- DOI: 10.1182/blood.2022019339
Queen's gambit: response-adapted win in CAYA with cHL
Comment on
-
Nivolumab and brentuximab vedotin with or without bendamustine for R/R Hodgkin lymphoma in children, adolescents, and young adults.Blood. 2023 Apr 27;141(17):2075-2084. doi: 10.1182/blood.2022017118. Blood. 2023. PMID: 36564047 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous